MedPage Today on MSN
Study finds surprising link between aspirin in seniors and cancer mortality
Longer follow-up of the ASPREE cohort is warranted, says researcher ...
President Donald Trump has said on multiple occasions in recent months that he takes a “large” dose of aspirin to prevent cardiovascular disease. His comments could perpetuate a common misperception, ...
Researchers say that a daily routine of low-dose aspirin does not appear to reduce the risk of cancer in older adults.
UK cardiologist, Professor Malcolm Finlay, has issued an important warning for anyone who takes aspirin daily due to ...
A follow-up study suggests that aspirin therapy does not reduce cancer risk in older adults, but may instead increase cancer-related mortality risk.
A cardiologist has explained why it may not be beneficial for healthy people to take aspirin every day, as more than 2 ...
New research by Monash University has found that taking daily low-dose aspirin will not reduce long-term cancer risk in older adults.
Trump takes four times the recommended dose of aspirin for cardiac prevention. Even low-dose aspirin is no longer recommended ...
Study Finds on MSN
What works at 50 may backfire at 70: New aspirin-cancer study challenges conventional wisdom
In A Nutshell Starting aspirin after age 70 did not prevent cancer in a study of nearly 20,000 older adults followed for ...
Low-dose aspirin may limit cancer metastasis by inhibiting platelet activation and enhancing T-cell immunity, supporting biomarker guided use while balancing bleeding risk overall.
Britain is grappling with widespread shortages of aspirin, a vital medication for preventing strokes and heart attacks in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results